These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30308328)

  • 1. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
    Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
    J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
    Mosconi L; Rinne JO; Tsui WH; Berti V; Li Y; Wang H; Murray J; Scheinin N; Någren K; Williams S; Glodzik L; De Santi S; Vallabhajosula S; de Leon MJ
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5949-54. PubMed ID: 20231448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
    Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
    Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter fiber density abnormalities in cognitively normal adults at risk for late-onset Alzheimer's disease.
    Sánchez SM; Duarte-Abritta B; Abulafia C; De Pino G; Bocaccio H; Castro MN; Sevlever GE; Fonzo GA; Nemeroff CB; Gustafson DR; Guinjoan SM; Villarreal MF
    J Psychiatr Res; 2020 Mar; 122():79-87. PubMed ID: 31931231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Structural and Amyloid Correlates of Recovery From Semantic Interference in Cognitively Normal Individuals With or Without Family History of Late-Onset Alzheimer's Disease.
    Abulafia C; Loewenstein D; Curiel-Cid R; Duarte-Abritta B; Sánchez SM; Vigo DE; Castro MN; Drucaroff LJ; Vázquez S; Sevlever G; Nemeroff CB; Guinjoan SM; Villarreal MF
    J Neuropsychiatry Clin Neurosci; 2019; 31(1):25-36. PubMed ID: 30305005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the Spatial Associations Between Amyloid-β Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
    Jorge L; Martins R; Canário N; Xavier C; Abrunhosa A; Santana I; Castelo-Branco M
    J Alzheimers Dis; 2021; 80(1):113-132. PubMed ID: 33523050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
    Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ
    Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.
    Rosenbloom MH; Alkalay A; Agarwal N; Baker SL; O'Neil JP; Janabi M; Yen IV; Growdon M; Jang J; Madison C; Mormino EC; Rosen HJ; Gorno-Tempini ML; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neurology; 2011 May; 76(21):1789-96. PubMed ID: 21525424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β associated cortical thinning in clinically normal elderly.
    Becker JA; Hedden T; Carmasin J; Maye J; Rentz DM; Putcha D; Fischl B; Greve DN; Marshall GA; Salloway S; Marks D; Buckner RL; Sperling RA; Johnson KA
    Ann Neurol; 2011 Jun; 69(6):1032-42. PubMed ID: 21437929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of cortical thinning in Alzheimer's disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70.
    Keuss SE; Coath W; Cash DM; Barnes J; Nicholas JM; Lane CA; Parker TD; Keshavan A; Buchanan SM; Wagen AZ; Storey M; Harris M; Lu K; James SN; Street R; Malone IB; Sudre CH; Thomas DL; Dickson JC; Barkhof F; Murray-Smith H; Wong A; Richards M; Fox NC; Schott JM
    J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):748-752. PubMed ID: 38199813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA and glutamate moderate beta-amyloid related functional connectivity in cognitively unimpaired old-aged adults.
    Quevenco FC; Schreiner SJ; Preti MG; van Bergen JMG; Kirchner T; Wyss M; Steininger SC; Gietl A; Leh SE; Buck A; Pruessmann KP; Hock C; Nitsch RM; Henning A; Van De Ville D; Unschuld PG
    Neuroimage Clin; 2019; 22():101776. PubMed ID: 30927605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between astrocyte reactivity, using novel
    Livingston NR; Calsolaro V; Hinz R; Nowell J; Raza S; Gentleman S; Tyacke RJ; Myers J; Venkataraman AV; Perneczky R; Gunn RN; Rabiner EA; Parker CA; Murphy PS; Wren PB; Nutt DJ; Matthews PM; Edison P
    Mol Psychiatry; 2022 Apr; 27(4):2019-2029. PubMed ID: 35125495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.